Mitsubishi Tanabe Pharma sells drug sales unit
Oct 2(Reuters) - Mitsubishi Tanabe Pharma Corp <4508.T>:Says it sold 100 percent stake in a drug sales unit to Nipro, on Oct. 1.Previous plan was announced on March 28.
Latest Developments forMitsubishi Chemical Holdings Corp
- Hitachi Intends To Auction Its Unit Hitachi Chemical As Early As May - Nikkei
- Mitsubishi Tanabe Pharma completes purchase of NeuroDerm
- Mitsubishi Chemical's operating profit apparently grew 30 pct for April-June quarter - Nikkei
- Mitsubishi Chemical Holdings consolidated subsidiary to buy NeuroDerm for about $1.1 bln